ICYMI: A Summary of Annual Meeting 2019 Blog Posts
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Category: In the News
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Although checkpoint inhibitors and other immunotherapies are remarkably effective for patients with some cancers, demonstrating durable antitumor activity and/or...
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
Like many Americans, Dr. Jill Biden has been personally affected by cancer. Friends, her parents, and her son Beau...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
February 11 marks the International Day of Women and Girls in Science, a United Nations initiative to encourage full...
In the final weeks of 2018, the U.S. Food and Drug Administration (FDA) announced three approvals of anticancer therapeutics....
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
The past two weeks have seen a flurry of U.S. Food and Drug Administration (FDA) approvals of new treatments...